• Users Online: 8
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login

Current Issue

January-June 2018| Vol 4| Issue 1


Omalizumab in the treatment of chronic urticaria

Omalizumab (OMA) has been approved by the Drug Controller General of India (DCGI) in 2013 for the treatment of urticaria. OMA, a humanized monoclonal antibody against the constant region of the immuno...

Review Article

Bilastine: A novel antihistamine

Bilastine is a new second generation H1-antihistamine approved for the symptomatic treatment of allergic rhinitis (AR) and chronic urticaria (CU) in patients older than 12 years of age. AR and urticar...

Original Article

Comparision of oral levofloxacin and minocycline in treatment of inflammatory acne vulgaris: A randomized control trial

Background: Acne vulgaris is a chronic inflammatory disease of pilosebaceous units. This disease occurs worldwide and usually starts in adolescence and resolves by mid-twenties. It is the most ...

Original Article

Use of over-the-counter topical medications in dermatophytosis: A cross-sectional, single-center, pilot study from a tertiary care hospital

Background: Dermatophytosis is a common, superficial fungal infection of the skin. In developing countries like India, casual attitude toward seeking medical attention and lax drug control poli...

Brief Report

Role of omalizumab in refractory chronic spontaneous urticaria: A single referral center experience

Background: Multiple evidence have shown that omalizumab, a subcutaneous (SC) anti-IgE monoclonal antibody, is highly effective for the treatment of chronic spontaneous urticaria (CSU). Obj...

View All Articles in the Current Issue

Indian Journal of Drugs in Dermatology, ia an official publication of Indian Association of Dermatologists, Venereologists and Leprologists (IADVL) ) supported by Maharashtra Branch of IADVL. IJDD is a peer-reviewed online journal with Semiannual print on demand compilation of issues published. The journal’s full text is available online at http://www.ijdd.in.

Features of Manuscript Management System

  • Online submission
  • Wider visibility through open access
  • Higher impact
  • Prompt review
Submit Article Subscribe Most Popular Articles Join as Reviewer Email Alerts Recommend this journal to your library or friends

Abstracting and Indexing Information

The journal is registered with the following abstracting partners:
Baidu Scholar, CNKI (China National Knowledge Infrastructure), EBSCO Publishing's Electronic Databases, Ex Libris – Primo Central, Google Scholar, Hinari, Infotrieve, National Science Library, ProQuest, TdNet, Wanfang Data

The journal is indexed with, or included in, the following:
Index Copernicus